Current Residents
Hsing-Yi (Yuki) Lin, PharmD
PGY1 International Graduate Pharmacy Resident
Email: hlin2@houstonmethodist.org
Yuki was born in Japan and raised in Taiwan. She attended the Ohio State University for her undergraduate studies. She obtained her Doctorate of Pharmacy degree from the University of California, San Francisco in 2023. In her spare time, she enjoys writing postcards, traveling, and exploring new restaurants.
Major research project: Impact of meropenem restriction criteria implementation on prescribing trends, clinical outcomes, and resistance patterns
Quality improvement project: Evaluation of Argatroban and Bivalirudin
Continuing education program: Inflammatory Bowel Disease
PGY1 International Graduate Pharmacy Resident
Email: hlin2@houstonmethodist.org
Yuki was born in Japan and raised in Taiwan. She attended the Ohio State University for her undergraduate studies. She obtained her Doctorate of Pharmacy degree from the University of California, San Francisco in 2023. In her spare time, she enjoys writing postcards, traveling, and exploring new restaurants.
Major research project: Impact of meropenem restriction criteria implementation on prescribing trends, clinical outcomes, and resistance patterns
Quality improvement project: Evaluation of Argatroban and Bivalirudin
Continuing education program: Inflammatory Bowel Disease
Mealis Taouk, PharmD
PGY1 International Graduate Pharmacy Resident
Email: mtaouk@houstonmethodist.org
Born and raised in Lebanon, Mealis obtained her Doctor of Pharmacy Degree from the Lebanese American University in 2022. Her current professional interest is oncology and aspires to pursue a PGY2 residency position in this field. In her free time, Mealis enjoys working out, snowboarding, and traveling.
Major Research Project: Impact of novel Tetracycline derivatives in the treatment of Mycobacterium Abscessus pulmonary infections.
Quality Improvement Project: Intravenous Regular Insulin Administration for Hyperkalemia Management
Continuing Education Program: Management of Infusion Reactions to Systemic Chemotherapy